Evaluation of cytotoxic and apoptotic effetcs of novel transition metal complexes against T-24 bladder cancer cells
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Background: Inspired by cisplatin’s success, this study synthesized and characterized Cu, Zn, and Co metal complexes with an amine ligand. Platinum-based compounds were the first metal drugs to inhibit cancer cell growth. Aim: This study aimed to evaluate the cytotoxicity, cellular apoptosis, and nuclease activities of [M(Me6tren) Cl]PF6 (M = Cu (II), Zn, Co) on T-24 (bladder transitional cell carcinoma). Materials and Methods: The in vitro antitumor effects of these three metal amine complexes were assessed on T-24 cells using the SRB (sulforhodamine B) assay after 48 hours, compared to cisplatin. Apoptosis induction was analyzed by flow cytometry with Annexin V-FITC at 0.2, 0.1, and 0.05× IC50 concentrations. Nuclease activity was also assessed using pUC19. Results: Elemental microanalyses confirmed the complexes matched the assigned formula [M(Me6tren) Cl]PF6. Cytotoxicity assays showed that the three complexes inhibited cell growth dose-dependently but were less potent than cisplatin. Flow cytometry indicated that ~20% of the IC50 of cisplatin and the copper complex increased cell death from 0.8% to 2.97% and 3.63%, respectively. Increasing [Cu (Me6tren) Cl]PF6 increased DNA cleavage to 48.76%, while 450 µM of [Zn (Me6tren) Cl]PF6 fully degraded pUC19, aligning with cytotoxicity results. Conclusion: These new metal amine complexes showed anti-tumor activity although lower than cisplatin. The Cu and Zn complexes bound to DNA and influenced its cleavage; their effects on cell viability and apoptosis depend more on the complex’s structure than on the metal or ligand alone.
Fields of Study & Subjects
Metal complexes synthesis and properties
Inorganic and Organometallic Chemistry
Cancer therapeutics and mechanisms
Publication details
- Journal / source
- Egyptian Journal of Cancer and Biomedical Research.
- Volume
- 10
- Issue
- 1
- Publication date
- 1 March 2026
- Language
- EN